BPG is committed to discovery and dissemination of knowledge
Clinical Trials Study
Copyright: ©Author(s) 2026.
World J Diabetes. Jul 15, 2026; 17(7): 119604
Published online Jul 15, 2026. doi: 10.4239/wjd.119604
Figure 3
Figure 3 Cumulative incidence functions (Aalen-Johansen) with adjusted 2-year cumulative incidence function. Panels show Aalen-Johansen cumulative incidence curves for progression to diabetes, regression to normoglycemia, and persistence of prediabetes across the four metabolic subtypes. Shaded bands indicate 95% confidence intervals from 500 bootstrap resamples, and the vertical dotted line marks 2 years. Tables below each panel summarize sample size, events, last event time, unadjusted 2-year cumulative incidence, adjusted 2-year cumulative incidence, and 95% confidence intervals. Adjusted 2-year cumulative incidence was estimated with Fine-Gray competing risk models and marginal standardization, adjusting for subtype, intervention, and sex. MARD: Mild age-related dysmetabolism; MOD: Mild obesity-related dysmetabolism; SID: Severe insulin deficiency; SIR: Severe insulin resistance; CI: Confidence interval.


Write to the Help Desk